Iclaprim is a diaminopyrimidine antibiotic that functions as a dihydrofolate reductase inhibitor. As a potent investigational agent, it has been studied for its ability to disrupt bacterial DNA replication… Read more
Iclaprim is a diaminopyrimidine antibiotic that functions as a dihydrofolate reductase inhibitor. As a potent investigational agent, it has been studied for its ability to disrupt bacterial DNA replication and cell division, demonstrating significant in vitro activity against various Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus. In pharmaceutical research and development, high-quality reference standards are essential for characterizing this compound and ensuring the accuracy of analytical procedures. Laboratories utilize Iclaprim impurities, metabolites, and stable isotope-labelled standards to support comprehensive impurity profiling and the validation of analytical methods. These materials provide the necessary precision for quantitative analysis and quality control, enabling researchers to maintain rigorous standards during drug substance evaluation and stability testing. By incorporating these specialized compounds into analytical workflows, scientists can reliably identify and monitor degradation products and metabolic pathways throughout the development and manufacturing lifecycle.